Clinical Trials Directory

Trials / Completed

CompletedNCT03880747

Dumping Syndrome and Quality of Life After Vagus Nerve-preserving Distal Gastrectomy

Incidence of Dumping Syndrome After Laparoscopic Vagus Nerve-preserving Distal Gastrectomy for Early Gastric Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Seoul National University Bundang Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

There is no consensus on what type of function-preserving gastrectomy can provide the best patient quality of life (QOL). This study aims to evaluate the incidence of dumping syndrome after vagus nerve-preserving distal gastrectomy (VPNDG).

Detailed description

The study is designed as a prospective observational phase II study with a follow-up period of 12 months. Patients diagnosed with early gastric cancer in the distal 2/3rd of the stomach who are planned to undergo laparoscopic VPNDG with Roux-en Y gastrojejunostomy will be enrolled. Primary endpoint is incidence of dumping syndrome defined by Sigstad score 7 after a 3-month interval. Other outcomes include operative data, early complication, and patient QOL using the European Organization for Research and Treatment of Cancer C-30 and STO22 modules.

Conditions

Interventions

TypeNameDescription
PROCEDUREVagus nerve-preserving distal gastrectomyLaparoscopic distal gastrectomy with the preservation of the celiac and hepatic branch of the vagus nerve.

Timeline

Start date
2017-08-09
Primary completion
2019-08-19
Completion
2020-08-20
First posted
2019-03-19
Last updated
2021-03-09

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03880747. Inclusion in this directory is not an endorsement.